Rating: Neutral | Target Price: RMB 7.0–8.6 (base-case fair value range, midpoint RMB 7.8) | Current Price: RMB 8.04 (close, 2026-10-29) | Margin of Safety: -13% (base-case fair value floor of RMB 7.0 sits below the current price — no discount protection) | Time Horizon: 6–12 months
| Meta | Value |
|---|---|
| Closing price (2026-10-29) | RMB 8.04 (valuation anchor of this report) |
| Total shares / market cap | 9.016 billion shares / RMB 72.489 billion |
| PB (LF) | 0.74x (book value per share RMB 10.81; equity attributable to shareholders RMB 97.460 billion as of 2026-09-30) |
| Core valuation anchor | PB percentile (8% over 5 years, 4% over 10 years); PE distorted by profit collapse (TTM ~699x, reference only) |
China Merchants Shekou (CMSK) is one of the few state-owned developers in this property downturn that has "held its sales scale against the trend while keeping its credit intact": contracted sales of RMB 140.093 billion in January–September 2026, roughly flat YoY, versus a 13.9% decline in national commodity housing sales over the same period; its No. 4 industry ranking and a blended funding cost of 2.61% form the floor of its asset quality. But earnings are still searching for a bottom — net profit attributable to shareholders of RMB 0.604 billion (-75.8%) in the first three quarters was entirely contributed by non-recurring gains, with non-GAAP (ex-non-recurring) results already posting a loss of RMB 0.527 billion. Whether full-year attributable profit stays positive hinges on whether the ~RMB 0.5 billion one-off revaluation gain from the Zhaohua Convention & Exhibition acquisition can be booked within the year; the historical pattern of concentrated impairment charges in Q4 (RMB 6.034 billion in full-year 2024 and RMB 4.410 billion in 2025, versus only RMB 0.066 billion in the first three quarters of 2026) is the single largest swing factor. At RMB 8.04, the price implies a PB of 0.74x, at a historically low percentile; however, solving backward, it implies a long-term ROE of ~7%, while the company's actual ROE has fallen below 1% and this report's normalized estimate supports only 3.6–4.6% — the current price already embeds "impairment contained + earnings recovery, at least one of which materializes"; the valuation is fair with no margin of safety. The probability-weighted fair value across three scenarios is ~RMB 7.9, roughly -1.5% versus the current price; downside to the bear-case midpoint is ~-39%, upside to the bull-case midpoint ~+46% — odds roughly symmetric but slightly expensive. Conclusion: good quality, fair price — insufficient risk-reward for left-side positioning. We recommend right-side validation via three checkpoints: the January 2027 earnings preannouncement (impairment magnitude), monthly sales bulletins, and the commercial REIT issuance pricing.
Nature of the opportunity: This is an event-driven trade, not a discount-buying allocation. Over the next 6–12 months, share price direction will be decided by three falsifiable events rather than one-sided industry beta: ① the scale of Q4 impairment charges and the sign of full-year attributable profit in the January 2027 earnings preannouncement; ② whether the commercial REIT (Prince Plaza + Garden City, valued at RMB 2.864 billion) can complete issuance and pricing before the hard deadline of 2027-03-20, providing a market-based anchor for RMB 142.7 billion of investment properties carried at cost; ③ whether monthly sales bulletins confirm the Q4 run rate of ~RMB 18.6 billion per month (up 27.5% from the Q3 monthly average) needed to hit management's target of "matching 2025 full-year sales (RMB 196.0 billion)."
Driver ranking: impairment magnitude (full-year loss risk, an EPS swing of ±RMB 0.2 either way) > stabilization of contracted sales (supports PB recovering toward base case) > REIT pricing (precondition for the bull case). Expectation gap: consensus among sell-side (35 covering brokers: 27 Buy, 24 Outperform, none below Neutral) is 2026E EPS of RMB 0.10 and 2027E RMB 0.20, with a median target price of RMB 10.3 — a target built on PB mean reversion rather than an earnings anchor, with consensus EPS already cut 28.6% over the past 90 days. This report's 2026E attributable profit midpoint of ~RMB 0.6 billion is ~RMB 0.3 billion below consensus of ~RMB 0.9 billion; the disagreement centers on Q4 impairment. Validation and falsification: the three events above are the triggers. If attributable profit turns negative in the preannouncement, or Q4 impairment ≥RMB 4.0 billion, or the exhibition gain is deferred to 2027, the probability weight of the base case (45%) sliding toward the bear case rises significantly; conversely, if impairment ≤RMB 1.5 billion and the REIT issues smoothly, PB should recover from 0.74x toward 0.8–0.9x (roughly RMB 9.2–9.7 per share).
The outperformance is real: SOE credit (blended funding cost of 2.61% in 2026H1, in the industry's lowest band) + extreme focus (in 2026H1, investment in "core 10 cities" approached 100%; tier-1 cities accounted for 63% of 2025 land investment — an investment-caliber figure). But three constraints must be stated alongside: first, Q3 contracted sales were ~RMB 43.8 billion, about -15% YoY (vs +8.3% in H1 — momentum has reversed, with September alone at RMB 14.322 billion, down another ~9% MoM); second, the market share gain partly reflects the arithmetic effect of a shrinking industry denominator — if national sales stop falling in 2027, the "share" from the same sales amount will automatically decline; third, hitting the Q4 target requires ~RMB 18.6 billion per month, up 27.5% from the Q3 monthly average, while management explicitly stated at the earnings call that 2026 supply is "concentrated in the first half" — a low-base YoY narrative is not equivalent to a high-velocity sequential requirement. Competing head-to-head with other SOEs (RMB 59.4 billion of land acquired at attributable basis in 2025, including multiple high-premium plots) also means "focus" in land acquisition is zero-sum, and the gross-margin recovery dividend may be eroded by land prices.
Delivery gross margin has declined year after year (15.89% → 14.61% → 13.76% → 12.48% in the first three quarters of 2026); investment income for the first three quarters was only RMB 0.093 billion (JVs/associates at -RMB 0.523 billion vs +RMB 0.058 billion a year ago) and is still deteriorating. Whether full-year attributable profit stays positive depends heavily on the exhibition gain being recognized within the year — a gain that is an accounting revaluation from cash-for-control (the company consolidates an operating company with net assets of -RMB 0.109 billion and, at a 50% share, bears RMB 3.421 billion of joint CDB loan guarantees); the business registration change is still in progress, so recognition timing could be deferred. Per this report, core business recovery will not come until 2027 (attributable profit RMB 1.5–3.0 billion, midpoint ~RMB 2.2 billion) — a range more optimistic than sell-side consensus (~RMB 1.8 billion); the disagreement lies in the pace of impairment cleanup and the gross margin structure of new projects.
"Nibbling in the first three quarters, one-off cleanup in Q4" has repeated for years, and with inventory of RMB 356.2 billion and national home prices not yet uniformly stabilized, our base case assumes 2026Q4 charges return to the RMB 3.0–5.0 billion scale; if charges ≥RMB 4.0 billion or the exhibition gain is deferred, we estimate full-year attributable profit of roughly -RMB 0.6 to -2.9 billion. Countervailing evidence must also be weighed: inventory write-downs in 2020–2024 were RMB 2.530/1.719/3.641/2.276/3.575 billion — not RMB 4-billion-scale every year; in September, first-tier new home prices turned to MoM gains in the 70-city index with the number of rising cities expanding to 17; and after two consecutive years of charges in 2024–2025, some projects have already been written down — the magnitude could come in below market fears. Another easily overlooked sensitivity: if the Q4 delivery base shrinks (Q3 revenue from handovers already -25.13%) and profit ex-impairment falls below the year-ago level of ~RMB 2.8 billion, then even RMB 1.5–2.0 billion of charges would suffice to flip the full year to a loss. The January 2027 earnings preannouncement is the sole validation checkpoint.
Rising contract liabilities lock in the 2027 delivery base, operating cash flow has turned sharply positive, and the 2.61% funding cost — these three points support the judgment that "survival and delivery are not in question," clearly distinguishing it from a Vanke-style unwind. But two corrections to commonly optimistic readings: first, roughly half of the +904% operating cash flow came from contraction in land and construction payments (cash paid for goods and services -21.3%) rather than pure collections improvement; second, on a direct balance-sheet summation, net debt is ~RMB 140.2 billion (~RMB 15.5 per share, exceeding book equity per share of RMB 10.81), and the company's reported net gearing rose ~25pp over two years (from ~47% in 2023H1 to 64.93% in 2026H1). Minority interests account for 64% of total equity while minority P&L has been persistently negative (-RMB 0.117 billion in the first three quarters of 2026) — this divergence between equity and earnings points to complexity in JV partner funding structures, a hidden thread to monitor beneath the "safety cushion" narrative.
The industrial park REIT's second expansion has been filed (the first in China to complete two rounds), and a rental housing REIT expansion is in preparation; the "develop–operate–capitalize–reinvest" pipeline is a scarce license among listed developers, directionally supporting asset value re-rating. But the extent of extrapolation must be constrained: this REIT anchors only ~RMB 2.86 billion of assets (2% of the RMB 142.7 billion portfolio), and office-attribute assets (Prince Plaza) are precisely the weakest class in the secondary market (as of 2026-08-18, the CSI REITs Total Return Index was -7.77% YTD with over 80% of constituents down); the revaluation range of -RMB 30 to +25 billion given at the scenario layer of this report (~±RMB 3 per share) is a rough sensitivity, not a precise calculation. REIT pricing is a directional adjudication point, but the evidentiary strength of a single data point is limited — exactly why confidence in this thesis is not high.
Solving backward at the current 0.744x PB implies a long-run steady-state ROE of ~6.7–7.1% (using a cost of equity of 9.0–9.5% in a zero-growth Gordon equivalence), corresponding to normalized attributable profit of RMB 6.5–6.9 billion (roughly the 2023 scale); the reality is an ROE trajectory of 6.04% → 3.36% → 0.73% → 0.62% in the first three quarters of 2026, with this report's normalization supporting only RMB 3.5–4.5 billion (ROE 3.6–4.6%) and sell-side 2026E at ~RMB 0.9 billion. Zero-growth EPV is ~RMB 4.2 per share, only ~52% of the current price — growth recovery plus the REITs option together account for ~48% of the price (not a high share for a growth stock, but for a company whose ROIC of 0.66% sits far below its cost of capital, the market's payment for "recovery" is already full). The probability-weighted fair value across three scenarios is ~RMB 7.9, about -1.5% versus the current price: the price sits slightly above the midpoint of the base-case range (RMB 7.0–8.6), with -39% downside to the bear-case midpoint and +46% upside to the bull-case midpoint. Conclusion: fair — neither a deep-discount margin-of-safety stock nor a stretched overvaluation; the sell-side RMB 10.3 target is built on PB mean reversion, and no covering analyst rates below Neutral (positive survivorship bias), so its achievement probability should be lower than its surface implication.
| Metric | 2023FY | 2024FY | 2025FY | 2026Q1–Q3 | 2026Q3 standalone |
|---|---|---|---|---|---|
| Revenue (RMB bn) | 175.008 | 178.948 | 154.728 | 83.447 (-7.04%) | 28.663 (-25.13%) |
| Attributable net profit (RMB bn) | 6.319 | 4.039 | 1.024 | 0.604 (-75.82%) | 0.076 (-92.78%) |
| Non-GAAP attributable net profit (RMB bn) | 5.733 | 2.449 | 0.169 | -0.527 (-126.80%) | -0.590 |
| Blended gross margin | 15.89% | 14.61% | 13.76% | 12.48% | — |
| Attributable net margin | 3.61% | 2.26% | 0.66% | 0.72% | 0.26% |
| Net operating cash flow (RMB bn) | 31.431 | 31.964 | 9.693 | 31.503 (+904.10%) | 7.368 |
| Weighted ROE | 6.04% | 3.36% | 0.73% | 0.62% | — |
| Contracted sales (RMB bn) | — | 219.302 | 196.009 | 140.093 (~-0.4% YoY) | ~43.8 (~-15% YoY) |
Balance-sheet stock (latest period, 2026-09-30): cash of RMB 97.300 billion (restricted only ~RMB 1 billion, per the 2026H1-end basis); interest-bearing debt of RMB 237.483 billion, net debt ~RMB 140.183 billion; gearing ratio 67.95% (62.98% ex-advance receipts, 2026H1); cash-to-short-term-debt ~1.57 on direct balance-sheet summation (company-disclosed basis 1.10 in 2026H1); blended funding cost 2.61% (2026H1; 3.47% in 2023). Perpetual bonds of RMB 12.03 billion were fully cleared in 2025. Industry-inapplicable metrics (net debt/EBITDA and other heavy-asset manufacturing calibers) are omitted.
Drivers of metric changes (company explanations attached for YoY ≥ ±20%): ① 2025 revenue -13.53% — lower scale of development project handovers (annual report note); ② sharp declines in 2025/2026 attributable and non-GAAP profit — lower handover scale + declining handover gross margin + lower investment income (annual report and Q3 report "reasons for change" columns); management added at the 2025 annual results briefing: RMB 4+ billion of impairments and RMB 3+ billion of held-property depreciation in 2025, "solidifying asset quality and traveling light"; ③ 2025 operating cash flow -69.67% — lower sales collections and higher land expenditure; first three quarters of 2026 +904.10% — "YoY increase in sales cash inflows and YoY decrease in land and construction payments" (Q3 report); ④ contract liabilities +21.82% from start of year — higher pre-sale receipts on undelivered projects; ⑤ 2025 investment income -81.81% — JV/associate income swung from +RMB 1.693 billion to -RMB 0.614 billion.
The central tension of the Q3 report (disclosed 2026-10-30) is "revenue falling faster than expected, profits nearly zeroed out": Q3 standalone revenue of RMB 28.663 billion (-25.13%), attributable net profit of only RMB 0.076 billion (-92.78%), non-GAAP -RMB 0.590 billion. The company attributes this to "uneven seasonal distribution of handovers, YoY decline in handover gross margin, and lower investment income." Three details stand out: first, within the RMB 1.131 billion of non-recurring gains in the first three quarters, RMB 0.547 billion came from non-current asset disposals — core-business losses masked by disposal gains, precisely the evidence for C2's "poor earnings quality"; second, JV/associate investment income was -RMB 0.523 billion (vs +RMB 0.058 billion a year ago), with partnership projects still a drag; third, the effective tax rate is abnormally high (income tax of RMB 1.330 billion vs total pre-tax profit of RMB 1.817 billion in the first three quarters, ~73%) — loss-making subsidiaries cannot offset taxes, which will amplify the impact of Q4 impairments on attributable profit. The positives are equally clear: operating cash flow of RMB 31.503 billion, contract liabilities rebounding to RMB 153.278 billion, and contracted sales of RMB 140.093 billion roughly flat YoY — collections and the pre-sale reservoir have both stabilized, giving a floor to 2027 deliveries. Relative to sell-side consensus (2026E attributable profit ~RMB 0.9 billion), the RMB 0.604 billion posted in the first three quarters means full-year delivery hinges heavily on Q4, leaving room for further downward revision to estimates before the earnings preannouncement; but the stock's rebound from RMB 7.32 in mid-October to RMB 8.04 suggests policy expectations (mortgage interest subsidies, Golden Week recovery) are already partially offsetting the earnings downgrades.
Business model snapshot: Asset-heavy presale-based developer. Development business (residential sales) accounts for 84.55% of revenue, asset operation (commercial/industrial parks/apartments/office buildings/hotels/MICE) 4.64%, and property management services (consolidated China Merchants Property Operation) 10.81%. Revenue is essentially carryover of "houses sold two years ago delivered this year," with no recurring subscription attributes; REITs capitalization in the asset operation segment is converting a portion of assets into "recyclable revolving capital," but the current scale (full-scope held-property revenue of RMB 7.63 billion) is not yet sufficient to change the profit structure. No independent pricing power—selling prices diverge with city tiers; in 2026H1 contracted sales value rose +8.27% while area fell -8.9%; the rise in average price came from the structural boost of Shenzhen luxury projects, not pricing power.
Cash content of earnings: Real estate companies' OCF includes land purchase expenditures, so ratio interpretation requires caution—OCF/net profit attributable to parent for 2023–2025 was 4.97x / 7.91x / 9.47x, and a staggering 52x for the first three quarters of 2026, mainly because profit collapsed faster than cash collections shrank, compounded by a sharp drop in land purchases—not a signal of "extremely high earnings quality"; however, directionally it shows the company is actively shrinking its balance sheet and collecting cash. FCF (OCF – fixed asset purchases)/net profit attributable to parent for 2024/2025 was 6.5x / 6.1x, likewise distorted by the low base. Recurring earnings test: 2025 net profit attributable to parent of RMB 1.024 billion vs. non-GAAP adjusted profit of RMB 169 million—about RMB 850 million came from non-recurring items (including RMB 579 million of investment income from the sale of Taiziwan Commercial Storage Property to a related party under the same controlling shareholder, representing 42.49% of total annual profit); core earnings were effectively near breakeven, and the adjusted profit turning negative in the first three quarters of 2026 confirmed this trend. Return on capital: Our estimate puts 2025 ROIC at roughly 0.66% (net profit of RMB 704 million + after-tax interest ≈ RMB 3.4 billion, divided by interest-bearing debt + equity of ≈ RMB 520 billion), far below the 2.61% financing cost—development, the core business, is currently in value-destruction territory, and profit recovery depends on the run-off of high-land-cost projects acquired in 2021–2023 and the carryover replacement from projects acquired after 2024 (management-stated gross margin of 15–20%). CapEx quality: 2025 fixed asset purchases of RMB 3.483 billion vs. investment property depreciation of RMB 3.675 billion (roughly 0.95x)—held-property investment has passed its peak; maintenance vs. growth CapEx split is not separately disclosed, preventing further distinction. Red flags: ① Net profit attributable to parent exceeded consolidated net profit (minority shareholders continuously absorbing losses); ② Abnormally high effective tax rate of 86.4% (2025) eroding earnings; ③ ROIC below cost of capital, relying on low-cost central-SOE credit to sustain expansion.
Consistency of words and deeds: pragmatic-leaning-cautious, high delivery rate, but fundraising projects are a blemish. ① Financing cost commitment—"continued reduction" delivered year by year: 3.47% (2023) → 2.99% (2024) → 2.74% (2025) → 2.61% (2026H1); ② Perpetual bond elimination commitment—full redemption of the RMB 12.03 billion outstanding perpetual bonds in 2025, delivered; ③ Dividend commitment—the 2026–2028 Shareholder Dividend Return Plan commits to a payout ratio of ≥40%; 2025 cash dividend ratio of 45.00% (including buybacks, 80.43% of net profit attributable to parent), delivered; ④ Fundraising projects—7 of 11 projects under the 2023 restructuring supporting fundraising failed to meet projected returns (Changchun cumulative -RMB 431 million, Shenyang -RMB 469 million), with the same list disclosed year after year—systematically optimistic projections, not delivered; ⑤ 2026 sales "broadly flat with 2025"—in progress, 71.5% completed through September; Q4 attainment is tight. Overall assessment: pragmatic, preferring low commitments with high delivery, but land acquisition projections have long skewed optimistic.
Shareholder friendliness: friendly. Cumulative cash dividends of RMB 6.429 billion for 2022–2024 (average payout ratio 43.97%); 44.804 million shares repurchased (RMB 430 million) from Nov 2024 to Oct 2025, all cancelled; elimination of perpetual bonds removed profit squeeze on ordinary shareholders. Dilution history: 2023 restructuring issuance of 602 million shares for asset purchase + 720 million shares for supporting fundraising—one-off.
Risk signals: ① Related-party transactions playing a profit-adjustment role—in 2025, RMB 579 million of gains recognized from the sale of Taiziwan assets to China Merchants Energy Shipping (42.49% of total profit); the ~RMB 500 million revaluation gain from the 2026 M&E acquisition is likewise a "reporting safety cushion"—the profit floor for two consecutive years came from asset transactions rather than the core business; ② On 2026-07-24, SDIC's 5.06% restricted shares become unlockable (commitment to a sale price of no less than RMB 14.83/share; deep inversion with the current price, so actual sale probability is low); ③ No disclosure of abnormal changes among key executives.
| Segment | 2025 Revenue Share | Gross Margin | YoY | Business Logic in One Sentence |
|---|---|---|---|---|
| Development | 84.55% | 15.33% (-0.25pp) | Revenue -16.33% | Residential development and sales; invest based on sales, focused on 10 core cities |
| Asset operation | 4.64% | -7.48% (2024: +1.35%) | Revenue +0.32% | Holding and operating commercial/industrial parks/apartments/office/hotel-MICE assets; REITs as exit |
| Property management | 10.81% | 10.59% (-0.28pp) | Revenue +8.35% | Consolidated China Merchants Property Operation; stable cash flows |
The profit engine is unquestionably the development business (gross profit contribution ≈ 84.6% × 15.33%, over 90% of the total). The gross margin gap across segments reaches 22.8pp (development 15.33% vs. asset operation -7.48%)—this is not a difference in the nature of the businesses, but an accounting convention: investment properties are measured at cost, with annual depreciation of over RMB 3 billion fully booked against the asset operation segment—management explicitly stated this convention at the 2025 results briefing; upon REITs issuance and deconsolidation, fair value is recognized in one lump sum, meaning the segment's book gross margin is a "distorted figure flattened by depreciation"—true profitability of asset operation is higher than book. Property management (China Merchants Property Operation: 2025 revenue of RMB 19.273 billion, +12.23%; net profit attributable to parent of RMB 655 million) is the only growing segment with real profits, but a high minority interest share post-consolidation limits attributable retention. Segment-based investment implications: short-term profit elasticity depends on the development carryover structure (new projects replacing old ones acquired after 2024), medium-term valuation elasticity depends on REITs revaluation of asset operation, and the long-term stabilizer is property management.
Accounting red flags: ① Inventory impairment pacing of "dripping through the first three quarters, clearing all at once in Q4" (RMB 6.034 billion in 2024 → RMB 4.410 billion in 2025 → only RMB 66 million in the first three quarters of 2026, with a single-quarter loss of RMB 1.473 billion in 2025Q4); year-end concentrated provisioning is prudent in direction but opaque in pacing (severity: medium); ② Abnormal swings in effective tax rate (53.9% → 86.4% → 73.2%); loss-making subsidiaries unable to offset taxes push up the consolidated rate, amplifying impairments' transmission to attributable profit (medium); ③ One-off related-party gains propping up profit (Taiziwan RMB 579 million, 42.49% of total profit) (medium); ④ 7 of 11 fundraising projects below expectations, disclosed repeatedly year after year (medium); ⑤ Investment properties measured at cost with no fair value revaluation (low—conservative rather than cosmetic, but fair value will be recognized in one lump sum at REITs issuance, giving strong control over the pace of profit release).
Cross-period consistency: ① Gross margin's continuous decline of 15.89% → 14.61% → 13.76% → 12.48% is consistent with management's explanation of "low-return legacy projects gradually digested, newly acquired better projects progressively carried over"; ② Year-by-year collapse of net margin attributable to parent is consistent with the annual report note of "declining carryover scale + reduced investment income"; ③ The concentrated pattern of impairments and Q4 profit—the company has not explained why it concentrates in Q4; ④ Large swings in OCF are consistent with the explanation of "reduced collections / contracted land purchases"; ⑤ Minority interest P&L of +2.787 → +150 → -320 → -117 million RMB (equity share 64%) is directionally consistent with management's explanation of "rising equity ratio in new projects," but the persistent divergence between equity and P&L still needs verification via partner transaction data in the annual report.
Current market data and percentiles: Closing price RMB 8.04 (2026-10-29), market cap RMB 72.489 billion. PB 0.744x (1-year 36% / 3-year 13% / 5-year 8% / 10-year 4% percentile); PE(TTM) 699x, PE percentile 100%—earnings are at a cyclical trough, so PE and its percentile are mechanically distorted, context only, not a valuation signal; dividend yield of 0.64% (2025 DPS of RMB 0.0511) offers no support for now. Peer benchmarks (PB caveat: HK-listed CR Land / COLI measure investment properties at fair value with revaluations already in net assets, while A-listed China Merchants Shekou uses cost method—horizontal PB comparison suffers from a convention illusion):
| Company | PB | 2025 Net Profit Attrib. | Gross Margin | Net Gearing | Key Difference |
|---|---|---|---|---|---|
| China Merchants Shekou | 0.74x | RMB 1.024 bn | 13.76% | 64.93% (company definition) | Cost-method net assets not revalued + REITs options |
| China Resources Land | 0.62x | RMB 25.42 bn | 21.2% | 39.2% | Recurring profit share 51.8%; valuation ceiling reference |
| China Overseas Land & Investment | 0.30x | RMB 12.69 bn | 15.5% | 34.2% | 12x Shekou's profit, lowest leverage |
| Poly Developments | 0.33x | RMB 1.03 bn | 12.7% | — | Largest by scale but profit at zero; discount floor reference |
| Vanke A | — | -RMB 88.56 bn | — | — | Cautionary tale of deep run-off (RMB 56.275 bn impairments in 2025) |
Market-implied expectations: Back-solving PB of 0.744x (Gordon-equivalent, cost of equity 9.0–9.5%, zero growth) implies a long-run steady-state ROE of ~6.7–7.1%, i.e., normalized attributable profit of RMB 6.5–6.9 billion—the current price requires earnings recovery back to 2023 levels, whereas in reality ROE has fallen below 1%, with an achievable normalization path of RMB 3.5–4.5 billion (our estimate) / RMB 900 million (sell-side 2026E). The combination of a low PB percentile (8% over 5 years) and elevated implied expectations means the market is pricing simultaneously between rock-bottom trust in net assets and a bet on "controllable impairments + earnings recovery"—the valuation debate here is essentially "normalized ROE of 4% or 7%?"
Three-tier value: ① Asset value (floor): BPS of RMB 10.81 (attributable equity of RMB 97.460 billion at 2026-09-30; perpetual bonds cleared, clean basis); current price is 74% of it—but this floor faces dual uncertainty from impairment erosion (bear case erodes another 10%) and investment property revaluation (two-way: -30 to +25 billion RMB); ② EPV, zero growth: normalized FCFE of RMB 3.2–4.4 billion ÷ cost of equity 9.5% ÷ 9.016 billion shares ≈ RMB 4.2/share, about 52% of the current price; ③ Growth recovery and REITs options: residual ~RMB 3.8/share (about 48% of the current price)—for an entity whose ROIC is below its cost of capital, the premium the market pays for recovery is already near full, but not yet bubble territory. Gaps in absolute-valuation inputs (project-level inventory values, carryover plans) are flagged as such; EPV serves only as a profitability reference tier and is not added to asset value.
Three scenarios and odds (PB/discount-to-net-assets basis; anchors independent of the current price: 1-year median PB of 0.79, A-share SOE discount band of 0.65–0.80, bridged from CR Land's 0.62x fair-value basis):
| Scenario | Probability | Fair Range | vs. Current Price | Decisive Factors |
|---|---|---|---|---|
| Bear | 30% | RMB 4.4–5.4 (PB 0.45–0.55 × eroded BPS of RMB 9.73) | Center -39% | Further ~10% net asset erosion from impairments + second leg down in sales + double-dip in home prices; investment property revalued at cap rate as a negative contributor |
| Base | 45% | RMB 7.0–8.6 (PB 0.65–0.80 × BPS of RMB 10.81) | Center -3% | Impairments converging below RMB 1.5 billion + 2027 gross margin recovering to 15–16% + flat sales (1–9 months -0.4% already on track) |
| Bull | 25% | RMB 10.5–13.0 (RNAV of RMB 13.03 × 0.85–1.0) | Center +46% | Commercial REIT premium issuance completed + investment property revaluation of +RMB 25 billion + attributable profit recovering to RMB 3.5–4.5 billion in 2027–2028 + core-city home prices stabilizing |
Probability-weighted fair value ≈ RMB 7.9, about -1.5% vs. the current price—current price sits slightly above the distribution center, odds roughly symmetric. Our forecasts vs. guidance vs. consensus: 2026E attributable profit—ours RMB 200 million–1.2 billion (center RMB 600 million) / no quantified management guidance / sell-side consensus ~RMB 900 million; 2027E—ours RMB 1.5–3.0 billion (center RMB 2.2 billion) / management says "profit pressure easing gradually" / sell-side consensus ~RMB 1.8 billion. Our below-consensus divergence point is the size of Q4 impairments; the above-consensus part (upper end of 2027) hinges on new projects delivering their gross margin structure.
Conclusion: fair. Target price RMB 7.0–8.6 (base-case fair value), margin of safety -13% (base-case fair-value floor below the current price). Quality (SOE credit, sales ranking, REITs licenses) and price (elevated implied expectations, no discount protection) assessed separately: high quality, fair price. Directional upside depends on two trackable variables—REIT pricing and impairment clearing; until then, the odds do not support heavy left-side positioning.
Industry size: China's mainland new home market recorded 2025 sales of RMB 8.39 trillion and sales area of 881 million sqm (NBS, -12.6%/-8.7% YoY), nearly half below the 2021 area peak; cumulative Jan–Sep 2026 sales of RMB 5.38 trillion (-13.9%) and area of 565 million sqm (-13.2%), with declines widening versus full-year 2025—the industry is in an "L-shaped crawl," not a V-shaped recovery. Structurally, the existing-home era is established: 2025 second-hand home registered transaction area was 737 million sqm; the second-hand share of transactions in the 30 core cities rose to ~65% (+4pp vs. 2024, China Index Academy), with new home demand shifting to upgrade-driven purchases. 3–5-year outlook: the China Index Academy (2026-01) judges that total volume is approaching the reasonable central level of "15th Five-Year Plan" housing demand and that the market could complete bottoming in the mid-to-late plan period; CR Land management (2026-03) judges "the hardest period has passed, entering a bottoming-out and deep-divergence cycle"; Poly's 2025–2026 Industry White Paper frames it as "a critical period of stabilization"—the consensus is low-single-digit stabilization rather than renewed expansion; no reliable quantitative CAGR forecast available.
Value chain and value distribution: Upstream land—exclusive supply by local governments; 2025 residential land GFA transacted in 300 cities of 620 million sqm (-14%) and land sale proceeds of RMB 2.3 trillion (-11%); average premium rate across 310 cities fell to 2% in December, but quality plots in core cities remain scarce (China Merchants Shekou's Qianhai residential plot in Jul 2025 at an 86.1% premium)—developers have extremely weak bargaining power on land. Funding—extreme credit stratification: China Merchants Shekou's Nov 2025 three-year corporate bonds priced at just 1.77%, while financing channels for defaulted and private developers are nearly shut (total developer financing of RMB 307.2 billion in the first three quarters of 2025, -30%). Downstream—homebuyer households; mortgage rates and down payments (minimum 15%) are at historically loose levels, but the constraint lies in income and employment expectations (2025 personal mortgages -17.8%). Value retention is migrating from development (gross margin squeezed to 10–16%) to holding/operation and asset management—CR Land's recurring businesses already contribute 51.8% of core net profit; China Merchants Shekou is replicating this path through three REITs (industrial parks, affordable housing, commercial) but at small scale (asset operation revenue of RMB 7.63 billion, under 5% of total).
Supply-demand and competitive landscape: Active supply contraction—2025 new starts of 588 million sqm (-20.4%, cumulative decline of ~75% from the 2021 peak), completions -18.1%, land transactions -12.4%; new home inventory across 100 cities of 392 million sqm, down YoY for 38 consecutive months (E-House); destocking cycle has retreated from the Nov 2025 peak of 27.4 months but remains near 29 months—Tier 1: 17.1 / Tier 2: 22.6 / Tier 3-4: 40.3 months (58 Anjuke)—"localized tightness in core cities + broad destocking" in parallel. Concentration: top-100 developers' 2025 sales of RMB 3.26 trillion, 38.8% of the national total (-2.4pct, China Index Academy)—the top-100's overall share actually fell amid private developer run-off, but leading SOEs concentrated counter-cyclically: 2025 CRIC full-caliber TOP5—Poly RMB 253.0 bn, COLI RMB 251.2 bn, CR Land RMB 233.6 bn, China Merchants Shekou RMB 196.0 bn, Greentown RMB 153.4 bn; only Binjiang Group among the TOP10 is a private firm. Entry barriers have shifted from land-acquisition capability to credit and capital: the Aug 28, 2026 tri-ministry Notice on Improving the Commodity Housing Sales System raised the presale threshold to "main structure topping out," with newly auctioned land prioritizing completed-unit sales—significantly lengthening capital lock-up cycles, further raising capital barriers, structurally reinforcing leading SOE advantages while suppressing industry-wide turnover and margins. Substitution threats: second-hand homes (65% share in 30 core cities) and the affordable housing system (1.21 million units/rooms started/raised in 2025) diverting entry-level demand.
Cycle and regulation: The industry is in its 5th year of deep adjustment, bottoming but not confirmed at a trough. Leading indicators: ① 100-city destocking cycle (retreating from highs); ② 70-city home price MoM (Tier 1 new homes turned positive from Jun 2026; 17 cities rising by September); ③ Second-hand registered transaction area (+10.7% Jan–Sep, recovering ahead of new homes); ④ Land premium rate (continuously falling; investment still cautious); ⑤ Developer funding inflows and mortgage growth. Regulatory主线—main policy thread: the "halt the decline and stabilize" overarching tone (Sep 2024 Politburo) → government purchase/stockpiling (PBoC affordable housing relending + local SOEs acquiring existing homes and idle land) → urban renewal (monetized resettlement of 1 million urban village units) → "good housing" new standards → the Aug 28, 2026 completed-unit sales reform → the Sep 29, 2026 Ministry of Finance 1% interest subsidy on first-home mortgages (≤120 sqm, total price ≤RMB 1.5 million, tentatively 1 year, expiring Oct 2027 pending review) → Oct 2026 National Day holiday: new home subscriptions across 50 cities +15% YoY. Policy direction is structurally favorable to leading SOEs (α divergence stronger than β recovery), but the shift to completed-unit sales imposes real new pressure on margins and turnover.
Company industry positioning: First-tier chaser → consolidating among leaders. 2025 CRIC rankings rose to 4th on both full-caliber and equity-caliber (RMB 132.3 bn, equity ratio 67.5%) bases; 5th on the China Index Academy basis (Greentown including agency construction)—the difference between the two bases stems from whether agency construction is counted, listed side by side for reference. Market share: 2.27% (2024) → 2.34% (2025) → 2.60% (Jan–Sep 2026, including the arithmetic effect of a shrinking industry denominator). Moat: central-SOE credit (financing cost of 2.61%, in the industry's lowest band; all "three red lines" green) + China Merchants Group and legacy Qianhai/Shekou resources + scarce three-platform REITs licenses + focus on 10 core cities (nearly 100% of 2026H1 investment; ranked 2nd in Shanghai on a full-caliber basis Jan–Aug). Weaknesses: deeply pressured earnings (attributable profit down -36%/-75%/-76% for three consecutive years), development gross margin still declining, net gearing above COLI/CR Land, and a significant asset-operation scale gap versus CR Land.
The core financial characteristic of real estate development is "contract sales first, revenue recognition later"—current-period profit is the residue of sales settled from two years ago, while current-period sales are the seeds of the future. Evaluating this case requires looking through the settlement table at four leading variables:
First, the scissors gap between contract sales and settlement. Contract sales: RMB 219.302 billion in 2024 → RMB 196.009 billion in 2025 (-10.62%) → RMB 140.093 billion in Jan–Sep 2026 (roughly -0.4% YoY); settlement: revenue -13.53% in 2025, -7.04% in the first three quarters of 2026. In 2026H1, contract sales value rose +8.27% while contract sales area fell -8.9%—volume down, price up, driven by the Shenzhen luxury-home mix, with questionable sustainability; Q3 momentum weakened (around -15%). Contract liabilities of RMB 153.278 billion (+21.8% from the start of the year, covering 99% of 2025 revenue) form the reservoir for 2027 revenue recognition; their rebound is the most positive fundamental signal in the Q3 report. The scissors gap between settlement gross margin (development: 15.33% → 15.35% in 2026H1) and the margin on newly acquired land (management guidance: 15–20%) has not yet converged—when it converges will determine the profit elasticity of 2027–2028.
Second, land bank and land acquisition intensity. Undeveloped land bank (products planned for development) is only 2.4727 million square meters, book value RMB 13.230 billion—about 0.35 years of sales volume; such thinness is rare among the TOP5, and the company responds with a "sales-driven investment" approach. In 2025, the company acquired 43 parcels / total land cost RMB 93.8 billion (RMB 54.3 billion payable), with the core 10 cities accounting for nearly 90% and first-tier cities 63% of investment. In 2026H1 this shrank to 9 parcels / RMB 18.4 billion (equity ratio rising to ~84%), with 7 more parcels added in Sep–Oct. Land acquisition intensity (total land cost / contract sales) was 47.9% in 2025—counter-cyclical expansion—which is both the ammunition for 2027 revenue recognition and a land-price risk to gross margin (parcels such as the Qianhai site at RMB 84,200 per square meter of floor area and the Chengdu Guixi parcel at a 70.4% premium will enter the impairment watch list if home prices fail to rise). A thin land bank plus expensive replenishment constitutes a "growth vs. margin" dilemma.
Third, financing stratification. Comprehensive funding cost: 3.47% → 2.99% → 2.74% → 2.61% (2026H1); three-year corporate bonds at a 1.77% coupon—the central-SOE credit dividend on the financing side is quantifiable and certain. Compared with the industry (private developers' public bond market closed; distressed developers' RMB 307.2 billion financing down 30%), this is both a moat and the first-order reason for share gains this cycle. The company is in the "green" zone on all three red lines (excluding advance receipts: 62.98% / net gearing 64.93% / cash-to-short-term-debt ratio 1.10, 2026H1), but net gearing has risen 25 percentage points over two years, with net debt on the balance sheet up roughly RMB 140.2 billion—the cost of expansion is accumulating on the leverage side.
Fourth, the REITs capitalization loop. Three platforms (industrial park REIT listed + expansion application filed; rental housing REIT listed + expansion in preparation; commercial REIT approved for 1 billion units / valuation RMB 2.864 billion / hard deadline 2027-03-20) + RMB 142.733 billion of investment properties measured at cost + consolidated China Merchants Hua Exhibitions—the "develop–operate–capitalize–reinvest" pipeline has taken shape. Management has explicitly stated that during the "15th Five-Year Plan" period, REITs expansions will drive the balance sheet "from heavy to light." If this loop works, it has three implications: one-off fair value realization (revaluation gains), recycled capital for reinvestment (RMB 2–3 billion per year per asset), and most importantly, establishing a market-based pricing anchor for cost-measured assets. Current constraints: single deal sizes are still small (about 2% of the portfolio), office REITs show the weakest secondary-market performance, and issuance windows depend on market sentiment.
Overall rating: Neutral, confidence 0.58, time horizon 6–12 months. China Merchants Shekou is a typical case of "high quality, average price": No. 4 central-SOE sales position, 2.61% funding cost, green-zone leverage, and scarce REIT licenses form the basic downside protection; but a core-loss-making position, the overhang of Q4 impairments, and a fully priced implied ROE expectation cap the upside. At the current price of RMB 8.04—slightly above the midpoint of the baseline fair-value range (RMB 7.0–8.6)—the margin of safety is -13%, with a probability-weighted expected return of about -1.5%. The odds do not support left-side positioning, but if the three checkpoints validate smoothly, the path to PB recovery toward 0.8–0.9x (about RMB 9.2–9.7) is clear.
Strategic implications: Holders may stay invested pending validation; incremental capital should wait for right-side signals—① January 2027 earnings preannouncement with impairment ≤ RMB 1.5 billion and positive attributable profit; ② successful commercial REIT issuance without pricing discount; ③ October monthly sales briefing with single-month sales ≥ RMB 18.6 billion. Conversely, if any one of the following occurs—attributable profit negative or impairment ≥ RMB 4 billion in the preannouncement, REIT postponed to the hard-deadline margin, or cumulative Q4 contract sales < RMB 48 billion—the valuation anchor shifts down to the bear-case range, at which point re-evaluate around RMB 6.3 (near the 52-week low).
Risk and catalyst calendar (next 6–12 months):
Risk warnings: ① Q4 impairment provisions exceed expectations (RMB 3–5 billion magnitude), turning full-year attributable profit negative and eroding net assets; ② a second nationwide sales downturn (the new completed-home sales policy lengthens capital occupation); ③ commercial REIT delayed or issued at a discount, downgrading the asset revaluation narrative; ④ risks in partner funding structures behind the divergence between minority shareholders' equity and their share of profit; ⑤ sentiment disturbance from Shenzhen Investment Holdings and the 2027-01 China Merchants Investment Development unlock (actual divestment probability is low: the former's sale price floor of RMB 14.83 is deeply inverted against the market, and the latter is a concert party of the controlling shareholder). Catalysts: ① China Merchants Hua Exhibitions' ~RMB 500 million gain booked + exposure of Shekou/Qianhai/Exhibition Bay assets at the Shenzhen APEC Summit on 2026-11-18/19; ② first validation window for mortgage interest subsidies (Q4 transactions); ③ fulfillment of the ≥40% payout ratio commitment in the 2026 annual report; ④ approval of the industrial park REIT's second expansion (the first two-round expansion in China).
Data and basis notes: The price anchor for this report is the 2026-10-29 closing price of RMB 8.04 (frozen basis); financial data as of the 2026 Q3 report (disclosed 2026-10-30); sales data as of the September 2026 sales briefing (2026-10-10); industry data as of the National Bureau of Statistics release on 2026-10-19. PB percentile and other market data are as computed on 2026-10-29. Unless otherwise specified, impairment figures refer to "total impairment losses" on the consolidated income statement (RMB 6.034 billion in 2024 / RMB 4.410 billion in 2025), which differs by about RMB 100 million from the "provision amounts" (RMB 5.94 / 4.27 billion) cited by media. Peer HK-listed data are on an announcement basis; PB cross-comparisons involve pricing-method differences (noted in the text).